1900 Wealth Management’s Idexx Laboratories IDXX Stock Holding History

1900 Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$452K	Buy	859 +6	+0.7%	+$3.37K	0.03%	190
2026 Q1	$479K	Buy	853 +1	+0.1%	+$641	0.03%	170
2025 Q4	$576K	Hold	852	–	–	0.04%	143
2025 Q3	$544K	Hold	852	–	–	0.04%	142
2025 Q2	$457K	Buy	852 +2	+0.2%	+$956	0.03%	155
2025 Q1	$357K	Buy	850 +75	+10%	+$32.6K	0.03%	170
2024 Q4	$320K	Buy	775 +50	+7%	+$21.9K	0.03%	182
2024 Q3	$366K	Hold	725	–	–	0.03%	175
2024 Q2	$353K	Sell	725 -150	-17%	-$75.3K	0.03%	180
2024 Q1	$473K	Hold	875	–	–	0.04%	163
2023 Q4	$486K	Hold	875	–	–	0.04%	195
2023 Q3	$383K	Hold	875	–	–	0.04%	214
2023 Q2	$440K	Sell	875 -40	-4%	-$19.2K	0.05%	168
2023 Q1	$373K	Hold	915	–	–	0.04%	179
2022 Q4	$373K	Hold	915	–	–	0.04%	177
2022 Q3	$298K	Sell	915 -70	-7%	-$25.7K	0.03%	189
2022 Q2	$346K	Buy	985 +360	+58%	+$147K	0.04%	180
2022 Q1	$342K	Buy	+625	New	+$329K	0.03%	195

Other funds holding IDXX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

1900 Wealth Management's IDXX Position: Q2 2026 in Review

1900 Wealth Management increased its Idexx Laboratories (IDXX) stake by 0.7% in Q2 2026, buying an estimated $3.37K and bringing the position to 859 shares worth $452K. The position accounts for 0.03% of the portfolio, ranked #190.

1900 Wealth Management first reported a position in IDXX in Q1 2022 and has held it in 18 quarters since. The position peaked at $576K in Q4 2025. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

1900 Wealth Management held 859 shares of Idexx Laboratories worth $452K as of Q2 2026.
1900 Wealth Management bought 6 Idexx Laboratories shares in Q2 2026, an estimated $3.37K.
Idexx Laboratories made up 0.03% of 1900 Wealth Management's portfolio in Q2 2026, its #190 holding.
1900 Wealth Management first reported a position in Idexx Laboratories in Q1 2022 and has held it in 18 quarters since.
1900 Wealth Management's Idexx Laboratories position peaked at $576K in Q4 2025.
1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on 1900 Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.